X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare ALEMBIC LTD with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC LTD vs SUN PHARMA - Comparison Results

ALEMBIC LTD    Change

Alembic Limited, in its 99 years of existence, has evolved from being a tincture manufacturer to one of the prominent indigenous pharma companies in India. It is among the top players in the macrolides (anti-infective) and anti-microbials (animal hea... More

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC LTD SUN PHARMA ALEMBIC LTD/
SUN PHARMA
 
P/E (TTM) x 53.2 28.1 189.3% View Chart
P/BV x 2.2 3.0 73.1% View Chart
Dividend Yield % 0.5 0.4 110.5%  

Financials

 ALEMBIC LTD   SUN PHARMA
EQUITY SHARE DATA
    ALEMBIC LTD
Mar-18
SUN PHARMA
Mar-18
ALEMBIC LTD/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs72701 10.3%   
Low Rs34433 7.8%   
Sales per share (Unadj.) Rs4.7110.4 4.3%  
Earnings per share (Unadj.) Rs6.111.0 55.6%  
Cash flow per share (Unadj.) Rs6.217.2 36.2%  
Dividends per share (Unadj.) Rs0.202.00 10.0%  
Dividend yield (eoy) %0.40.4 107.1%  
Book value per share (Unadj.) Rs40.7158.8 25.6%  
Shares outstanding (eoy) m267.032,399.26 11.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x11.35.1 219.4%   
Avg P/E ratio x8.751.6 16.8%  
P/CF ratio (eoy) x8.532.9 25.8%  
Price / Book Value ratio x1.33.6 36.5%  
Dividend payout %3.318.2 18.0%   
Avg Mkt Cap Rs m14,1391,360,021 1.0%   
No. of employees `000NA17.8 0.0%   
Total wages/salary Rs m20753,671 0.4%   
Avg. sales/employee Rs ThNM14,890.9-  
Avg. wages/employee Rs ThNM3,017.1-  
Avg. net profit/employee Rs ThNM1,480.6-  
INCOME DATA
Net Sales Rs m1,255264,895 0.5%  
Other income Rs m3708,388 4.4%   
Total revenues Rs m1,625273,282 0.6%   
Gross profit Rs m11156,081 0.2%  
Depreciation Rs m3814,998 0.3%   
Interest Rs m25,176 0.0%   
Profit before tax Rs m44244,295 1.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m1,2120-   
Extraordinary Inc (Exp) Rs m0-9,505 0.0%   
Tax Rs m248,452 0.3%   
Profit after tax Rs m1,63026,338 6.2%  
Gross profit margin %8.921.2 41.8%  
Effective tax rate %5.419.1 28.4%   
Net profit margin %129.89.9 1,306.0%  
BALANCE SHEET DATA
Current assets Rs m1,867316,359 0.6%   
Current liabilities Rs m591198,643 0.3%   
Net working cap to sales %101.644.4 228.7%  
Current ratio x3.21.6 198.3%  
Inventory Days Days9495 99.4%  
Debtors Days Days74108 68.3%  
Net fixed assets Rs m1,791213,178 0.8%   
Share capital Rs m5342,399 22.3%   
"Free" reserves Rs m10,324378,606 2.7%   
Net worth Rs m10,858381,006 2.8%   
Long term debt Rs m4117,721 0.2%   
Total assets Rs m11,591643,028 1.8%  
Interest coverage x260.99.6 2,729.4%   
Debt to equity ratio x00 8.2%  
Sales to assets ratio x0.10.4 26.3%   
Return on assets %14.14.9 287.2%  
Return on equity %15.06.9 217.2%  
Return on capital %15.210.0 151.5%  
Exports to sales %1.50-   
Imports to sales %21.00-   
Exports (fob) Rs m19NA-   
Imports (cif) Rs m263NA-   
Fx inflow Rs m1940,816 0.0%   
Fx outflow Rs m26430,143 0.9%   
Net fx Rs m-24410,673 -2.3%   
CASH FLOW
From Operations Rs m23639,072 0.6%  
From Investments Rs m-224-33,708 0.7%  
From Financial Activity Rs m-27-15,393 0.2%  
Net Cashflow Rs m-15-7,359 0.2%  

Share Holding

Indian Promoters % 64.0 63.7 100.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 5.1 3.9%  
FIIs % 9.7 23.0 42.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 26.1 8.3 314.5%  
Shareholders   54,701 133,026 41.1%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC LTD With:   ORCHID PHARMA LTD  CIPLA  ABBOTT INDIA  FULFORD INDIA  WYETH LTD  

Compare ALEMBIC LTD With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Rising Crude Oil Prices, Developments in the Automobile Sector, and Top Cues in Focus Today(Pre-Open)

Indian share markets ended their trading session on a strong note yesterday. Gains were largely seen in the oil & gas sector and telecom sector.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 265.5% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUN PHARMA has posted a net profit of Rs 15 bn (up 265.5% YoY). Sales on the other hand came in at Rs 77 bn (up 16.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (3QFY19); Net Profit Down 41.9% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, ALEMBIC LTD has posted a net profit of Rs 32 m (down 41.9% YoY). Sales on the other hand came in at Rs 243 m (down 18.8% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

SUN PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 20, 2018 | Updated on Dec 20, 2018

Here's an analysis of the annual report of SUN PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 110.7% (Quarterly Result Update)

Nov 14, 2018 | Updated on Nov 14, 2018

For the quarter ended September 2018, SUN PHARMA has posted a net profit of Rs 1 bn (down 110.7% YoY). Sales on the other hand came in at Rs 69 bn (up 4.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

ALEMBIC LTD Announces Quarterly Results (2QFY19); Net Profit Up 4.0% (Quarterly Result Update)

Nov 12, 2018 | Updated on Nov 12, 2018

For the quarter ended September 2018, ALEMBIC LTD has posted a net profit of Rs 294 m (up 4.0% YoY). Sales on the other hand came in at Rs 336 m (up 3.1% YoY). Read on for a complete analysis of ALEMBIC LTD's quarterly results.

More Views on News

Most Popular

This is Why the Stock of Jubilant FoodWorks Went Up 1,160%(The 5 Minute Wrapup)

Apr 12, 2019

This critical business strategy has enabled companies to scale their operations faster.

Pocketing Massive Gains with HDFC And HDFC Bank(Profit Hunter)

Apr 12, 2019

Here's how one could have generated gains of Rs 59,250 in 10 days by trading HDFC and HDFC Bank with a capital of Rs 4 lakh.

My Master Series on How to Trade Election 2019(Profit Hunter)

Apr 16, 2019

For 30 years he has watched how elections impact the markets, and practiced how to profit from it. Now he is here...telling you everything. Read on...

Election Series: Follow the World's Biggest Traders To See Where the Money Flows(The 5 Minute Wrapup)

Apr 17, 2019

20% of all the traders bring in 80% of the money. Watch these 20% and you get a working idea of which way the wind is blowing.

A Letter to You from India's No. 1 Trader(The 5 Minute Wrapup)

Apr 15, 2019

It's our great pleasure to introduce Vijay Bhambwani to our readers - we consider Vijay to be India's best trader. Read on to find out why...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC LTD SHARE PRICE


Apr 24, 2019 (Close)

TRACK ALEMBIC LTD

  • Track your investment in ALEMBIC LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ALEMBIC LTD 5-YR ANALYSIS

COMPARE ALEMBIC LTD WITH

MARKET STATS